PT  - JOURNAL ARTICLE
AU  - Simpson, D. M.
AU  - Gracies, J-M
AU  - Graham, H. K.
AU  - Miyasaki, J. M.
AU  - Naumann, M.
AU  - Russman, B.
AU  - Simpson, L. L.
AU  - So, Y.
TI  - Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]
AID  - 10.1212/01.wnl.0000311391.00944.c4
DP  - 2008 May 06
TA  - Neurology
PG  - 1691--1698
VI  - 70
IP  - 19
4099  - http://n.neurology.org/content/70/19/1691.short
4100  - http://n.neurology.org/content/70/19/1691.full
SO  - Neurology2008 May 06; 70
AB  - Objective: To perform an evidence-based review of the safety and efficacy of botulinum neurotoxin (BoNT) in the treatment of adult and childhood spasticity.Methods: A literature search was performed including MEDLINE and Current Contents for therapeutic articles relevant to BoNT and spasticity. Authors reviewed, abstracted, and classified articles based on American Academy of Neurology criteria (Class I–IV).Results: The highest quality literature available for the respective indications was as follows: adult spasticity (14 Class I studies); spastic equinus and adductor spasticity in pediatric cerebral palsy (six Class I studies).Recommendations: Botulinum neurotoxin should be offered as a treatment option for the treatment of spasticity in adults and children (Level A).